Home » Beyond Genomics Looks to Micromass for Instruments; Finds Second Pharma Partner

Beyond Genomics Looks to Micromass for Instruments; Finds Second Pharma Partner

Mar 04, 2002
Premium

After signing DiaDexus as its second pharmaceutical partner last month, Beyond Genomics last week chose Micromass to provide liquid chromatography and mass spectrometry equipment for the systems biology company’s proteomics platform.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Yep, Couple of Concerns There

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

Passing on Trauma, Maybe

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

Told to Pause

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

This Week in PNAS

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.

What's Popular?

In Proteomics & Protein Research

  1. Nanoparticle Enrichment Could Enhance Plasma Protein Biomarker Discovery

    Premium

  2. Proteogenomic Approach Identifies Candidate Tumor-Specific Antigens for Immunotherapies

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.